Home Pharmaceutics In the crowded cardio space, it’s David vs. Goliath for small biotechs

In the crowded cardio space, it’s David vs. Goliath for small biotechs

by Newsroom


This audio is auto-generated. Please let us know if you have feedback.

The cardiovascular space is filled with some of the biggest pharma and biotech players in the world. Not only did the weight loss phenomenon Wegovy score a cardiovascular indication last year, but giants like Merck & Co. are making moves, too. 

Merck anticipates…



Source link

You may also like

About Us

Pharma Newswire™ aggregates, publishes and distributes news in the Pharmaceutical Industry. In association with EmailWire, Pharma Newswire™ provides press release distribution services in the pharmaceutical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. To send a press release, contact us through the following messaging apps:

Pharma Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC